Altimmune, Inc.

ALT

$1.94

Name : Altimmune, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $376,975,296.00

EPSttm : -0.76

Altimmune, Inc.

$1.94

0.10%

$0.002

ALT — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

Margin Of Safety %

Put/Call OI Ratio

0.1

EPS Next Q Diff

-0.04

EPS Last/This Y

0.41

EPS This/Next Y

-0.08

Price

1.93

Target Price

17.11

Analyst Recom

1.3

Performance Q

-33.79

Upside

-629.4%

Beta

0.15

Ticker: ALT

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-12	ALT	2.57	0.12	0.10	181654
2026-10-13	ALT	2.43	0.12	0.05	181581
2026-10-14	ALT	2.3	0.12	0.67	182399
2026-10-15	ALT	2.37	0.12	0.15	183427
2026-10-16	ALT	2.19	0.12	0.12	183721
2026-10-19	ALT	2.22	0.12	0.02	179990
2026-10-20	ALT	2.3	0.12	0.07	181824
2026-10-21	ALT	2.23	0.11	0.07	182343
2026-10-22	ALT	2.16	0.11	0.07	182790
2026-10-23	ALT	2.11	0.11	0.06	182862
2026-10-26	ALT	2.04	0.12	0.03	183415
2026-10-27	ALT	2.04	0.11	0.02	185098
2026-10-28	ALT	2.09	0.11	0.34	185930
2026-10-29	ALT	2.13	0.11	0.13	186558
2026-10-30	ALT	2.04	0.11	1.13	187157
2026-11-02	ALT	2.01	0.11	0.39	186187
2026-11-03	ALT	2.06	0.11	0.06	186610
2026-11-04	ALT	2.12	0.11	0.35	187442
2026-11-05	ALT	1.97	0.11	0.02	187846
2026-11-06	ALT	2.09	0.11	0.22	188680
2026-11-09	ALT	2.115	0.10	0.02	188007
2026-11-10	ALT	1.935	0.10	0.14	188935
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-12	ALT	2.57	34.9	-	-0.59
2026-10-13	ALT	2.43	34.9	-	-0.59
2026-10-14	ALT	2.30	34.9	-	-0.59
2026-10-15	ALT	2.37	34.9	-	-0.59
2026-10-16	ALT	2.19	34.9	-	-0.59
2026-10-19	ALT	2.22	34.9	-	-0.59
2026-10-20	ALT	2.22	34.9	-	-0.59
2026-10-21	ALT	2.29	34.9	-	-0.59
2026-10-22	ALT	2.16	34.9	-	-0.59
2026-10-23	ALT	2.11	34.9	-	-0.59
2026-10-26	ALT	2.05	34.9	-	-0.59
2026-10-27	ALT	2.04	34.9	-	-0.59
2026-10-28	ALT	2.10	34.9	-	-0.59
2026-10-29	ALT	2.13	34.9	-	-0.59
2026-10-30	ALT	2.04	34.9	-	-0.59
2026-11-02	ALT	2.01	34.9	-	-0.59
2026-11-03	ALT	2.05	34.9	-	-0.59
2026-11-04	ALT	2.12	34.9	-	-0.59
2026-11-05	ALT	1.97	34.9	-	-0.59
2026-11-06	ALT	2.09	34.9	-	-0.59
2026-11-09	ALT	2.12	34.9	-	-0.59
2026-11-10	ALT	1.93	34.9	-	-0.59
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-12	ALT	0.14	34.92	25.09
2026-10-13	ALT	0.14	34.92	25.09
2026-10-14	ALT	0.14	34.92	25.09
2026-10-15	ALT	0.14	34.92	25.09
2026-10-16	ALT	0.14	34.92	25.09
2026-10-19	ALT	0.14	34.80	25.09
2026-10-20	ALT	0.14	34.80	25.09
2026-10-21	ALT	0.14	34.80	25.09
2026-10-22	ALT	0.14	34.80	25.09
2026-10-23	ALT	0.14	34.80	25.09
2026-10-26	ALT	0.14	34.48	25.09
2026-10-27	ALT	0.14	34.48	23.00
2026-10-28	ALT	0.14	34.48	23.00
2026-10-29	ALT	0.14	34.48	23.00
2026-10-30	ALT	0.14	34.48	23.00
2026-11-02	ALT	0.14	34.37	23.00
2026-11-03	ALT	0.14	34.37	23.00
2026-11-05	ALT	0.14	34.37	23.00
2026-11-06	ALT	0.14	34.37	23.00
2026-11-09	ALT	0.14	33.14	23.00
2026-11-10	ALT	0.14	33.14	23.00
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-0.12

Avg. EPS Est. Current Quarter

-0.14

Avg. EPS Est. Next Quarter

-0.16

Insider Transactions

0.14

Institutional Transactions

33.14

Beta

0.15

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

91.8

Max Drawdown 5-Year %

-91.2

Target Price

17.11

P/E

Forward P/E

PEG

P/S

12578.89

P/B

0.8

P/Free Cash Flow

EPS

-0.79

Average EPS Est. Cur. Y

-0.59

EPS Next Y. (Est.)

-0.67

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-296000

Relative Volume

1.02

Return on Equity vs Sector %

-45.6

Return on Equity vs Industry %

-25.9

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

◆ ALT Healthcare

$1.94

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

20/20

Pullback

15/25

Volume

4/15

Valuation

12/20

TP/AR

2/10

Options

7/10

RSI

Range 1M

2.8%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

13/25

Growth

17/30

Estimates

0/20

Inst/Vol

6/15

Options

10/10

EPS Yr

41.8%

EPS NY

-9.2%

52W%

0.4%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +782% upside

Quality

2/30

Valuation

16/30

Growth

12/25

Stability

8/10

LT Trend

4/5

Upside

+782%

Quality

ALT — P/E HistoricalBiotechnology

Altimmune, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 57

Altimmune, Inc., a late clinical stage biopharmaceutical company, focuses on developing novel therapies for serious liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis, alcohol use disorder, and alcohol-associated liver disease. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.

ALT

Latest News

—

Caricamento notizie per ALT…

stock quote shares ALT – Altimmune, Inc. Stock Price stock today

news today ALT – Altimmune, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch ALT – Altimmune, Inc. yahoo finance google finance

stock history ALT – Altimmune, Inc. invest stock market

stock prices ALT premarket after hours

ticker ALT fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: ALT

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y